Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: April 19, 2018

DrugPatentWatch Database Preview

Anchen Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?

ANCHEN PHARMS has twenty-five approved drugs.

There are two tentative approvals on ANCHEN PHARMS drugs.

Summary for Anchen Pharms

US Patents:	0
Tradenames:	21
Ingredients:	21
NDAs:	25

Drugs and US Patents for Anchen Pharms

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Anchen Pharms	MEMANTINE HYDROCHLORIDE	memantine hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	205784-001	Jun 9, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Anchen Pharms	DIVALPROEX SODIUM	divalproex sodium	TABLET, EXTENDED RELEASE;ORAL	078445-001	Feb 26, 2009	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Anchen Pharms	LAMOTRIGINE	lamotrigine	TABLET, EXTENDED RELEASE;ORAL	201374-001	Dec 26, 2012	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Anchen Pharms	LEVETIRACETAM	levetiracetam	TABLET, EXTENDED RELEASE;ORAL	091360-001	Oct 4, 2011	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Anchen Pharms

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla

Covington

Daiichi Sankyo

Johnson and Johnson

Dow

Medtronic

McKinsey

Fish and Richardson

Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.